Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Discover which travel rewards credit cards come with no fees. Enjoy your travels while saving money on fees.
26,830 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Barclays slashed Coinbase’s price target to $107 following aQ1 2026 revenue miss, highlighting a tug-of-war between c...
A new Girl Scouts survey reveals AI is now a regular companion for girls ages 5-13, often seen as a smarter tutor and...
A dramatic intraday surge in Plug Power stock highlighted the day’s market mood. This article unpacks the catalysts b...
A real-world case shows how the disabled adult child benefit can unlock substantial monthly income when a parent clai...
Nvidia is a cornerstone of the AI era, and its upcoming earnings can move markets. This guide breaks down what to con...
A new AI platform launch aims to empower independent brokerages to stay independent, compete scale, and win at scale ...
A legendary musician’s relentless pursuit of craft offers real-world money wisdom. Learn how to apply Sonny Rollins, ...
Triata Capital's sizable stake reduction in GDS Holdings has traders and investors buzzing about AI data-center expos...
A $600,000 annuity pays $3,700 a month in guaranteed income, but a spouse’s needs and legacy goals can change the mat...
Unilever faces a pivotal turnaround path as portfolio reshaping and a buyback program align with a potential rally to...
SpaceX has not announced an IPO date, but growing chatter centers on whether retail investors could drive a future pu...